SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-19-016739
Filing Date
2019-11-08
Accepted
2019-11-08 17:26:44
Documents
8
Period of Report
2019-11-07
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 34320
2 ex99-1.htm EX-99.1 6171
3 ex99-1_001.jpg GRAPHIC 322508
4 ex99-1_002.jpg GRAPHIC 464670
5 ex99-1_003.jpg GRAPHIC 83310
6 ex99-1_004.jpg GRAPHIC 195196
7 ex99-1_005.jpg GRAPHIC 175513
8 ex99-1_006.jpg GRAPHIC 252454
  Complete submission text file 0001493152-19-016739.txt   2099071
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences, Inc. (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36268 | Film No.: 191205131
SIC: 2835 In Vitro & In Vivo Diagnostic Substances